The Experts below are selected from a list of 126 Experts worldwide ranked by ideXlab platform
Michał Pawlaczyk - One of the best experts on this subject based on the ideXlab platform.
-
The effect of treatment for Vaginal Yeast Infection on the prevalence of bacterial vaginosis in early pregnancy.
Acta Dermatovenerologica Croatica, 2006Co-Authors: Michał Pawlaczyk, Zbigniew Friebe, Elżbieta Sowińska-przepiera, Joanna WlosinskaAbstract:Both bacterial vaginosis and candidiasis are commonly seen in pregnancy, with marked differences in pregnancy outcome. The aim of this study was to assess the effect of antifungal treatment on the prevalence of bacterial vaginosis in early pregnancy. This prospective randomized study included 126 women in early pregnancy with heavy Vaginal Yeast colonization and 88 healthy controls. Vaginal flora was evaluated on initial visit and on two check-ups for the presence of bacterial vaginosis. Half of the heavily colonized patients received an antimycotic agent (clotrimazole). The prevalence of vaginosis was compared among the three groups. Xi (2)-test and Fisher's exact test were used for statistical analysis. Three of 72 (4.2%) Yeast-free controls, two of 79 (2.5%) Yeast infected but not treated patients, and nine of 63 (14.3%) infected and treated patients presented with bacterial vaginosis 4 weeks after the initial visit. There was a statistically significant increase in the prevalence of bacterial vaginosis (p
-
the effect of treatment for Vaginal Yeast Infection on the prevalence of bacterial vaginosis in early pregnancy
Acta Dermatovenerologica Croatica, 2006Co-Authors: Michał Pawlaczyk, Zbigniew Friebe, Elzbieta Sowinskaprzepiera, Joanna WlosinskaAbstract:Both bacterial vaginosis and candidiasis are commonly seen in pregnancy, with marked differences in pregnancy outcome. The aim of this study was to assess the effect of antifungal treatment on the prevalence of bacterial vaginosis in early pregnancy. This prospective randomized study included 126 women in early pregnancy with heavy Vaginal Yeast colonization and 88 healthy controls. Vaginal flora was evaluated on initial visit and on two check-ups for the presence of bacterial vaginosis. Half of the heavily colonized patients received an antimycotic agent (clotrimazole). The prevalence of vaginosis was compared among the three groups. Xi (2)-test and Fisher's exact test were used for statistical analysis. Three of 72 (4.2%) Yeast-free controls, two of 79 (2.5%) Yeast infected but not treated patients, and nine of 63 (14.3%) infected and treated patients presented with bacterial vaginosis 4 weeks after the initial visit. There was a statistically significant increase in the prevalence of bacterial vaginosis (p<0.03) in Yeast infected and treated patients as compared to colonized and untreated patients. Treatment of candidiasis in early pregnancy may contribute to an increased rate of bacterial vaginosis.
Joanna Wlosinska - One of the best experts on this subject based on the ideXlab platform.
-
The effect of treatment for Vaginal Yeast Infection on the prevalence of bacterial vaginosis in early pregnancy.
Acta Dermatovenerologica Croatica, 2006Co-Authors: Michał Pawlaczyk, Zbigniew Friebe, Elżbieta Sowińska-przepiera, Joanna WlosinskaAbstract:Both bacterial vaginosis and candidiasis are commonly seen in pregnancy, with marked differences in pregnancy outcome. The aim of this study was to assess the effect of antifungal treatment on the prevalence of bacterial vaginosis in early pregnancy. This prospective randomized study included 126 women in early pregnancy with heavy Vaginal Yeast colonization and 88 healthy controls. Vaginal flora was evaluated on initial visit and on two check-ups for the presence of bacterial vaginosis. Half of the heavily colonized patients received an antimycotic agent (clotrimazole). The prevalence of vaginosis was compared among the three groups. Xi (2)-test and Fisher's exact test were used for statistical analysis. Three of 72 (4.2%) Yeast-free controls, two of 79 (2.5%) Yeast infected but not treated patients, and nine of 63 (14.3%) infected and treated patients presented with bacterial vaginosis 4 weeks after the initial visit. There was a statistically significant increase in the prevalence of bacterial vaginosis (p
-
the effect of treatment for Vaginal Yeast Infection on the prevalence of bacterial vaginosis in early pregnancy
Acta Dermatovenerologica Croatica, 2006Co-Authors: Michał Pawlaczyk, Zbigniew Friebe, Elzbieta Sowinskaprzepiera, Joanna WlosinskaAbstract:Both bacterial vaginosis and candidiasis are commonly seen in pregnancy, with marked differences in pregnancy outcome. The aim of this study was to assess the effect of antifungal treatment on the prevalence of bacterial vaginosis in early pregnancy. This prospective randomized study included 126 women in early pregnancy with heavy Vaginal Yeast colonization and 88 healthy controls. Vaginal flora was evaluated on initial visit and on two check-ups for the presence of bacterial vaginosis. Half of the heavily colonized patients received an antimycotic agent (clotrimazole). The prevalence of vaginosis was compared among the three groups. Xi (2)-test and Fisher's exact test were used for statistical analysis. Three of 72 (4.2%) Yeast-free controls, two of 79 (2.5%) Yeast infected but not treated patients, and nine of 63 (14.3%) infected and treated patients presented with bacterial vaginosis 4 weeks after the initial visit. There was a statistically significant increase in the prevalence of bacterial vaginosis (p<0.03) in Yeast infected and treated patients as compared to colonized and untreated patients. Treatment of candidiasis in early pregnancy may contribute to an increased rate of bacterial vaginosis.
D Janssens - One of the best experts on this subject based on the ideXlab platform.
-
the effect of antifungal treatment on the Vaginal flora of women with vulvo Vaginal Yeast Infection with or without bacterial vaginosis
European Journal of Clinical Microbiology & Infectious Diseases, 2011Co-Authors: Gilbert G G Donders, Gert Bellen, Jannie Ausma, L Verguts, J Vaneldere, P Hinoul, Marcel Borgers, D JanssensAbstract:Antibacterial therapy may enhance the risk of symptomatic vulvo-Vaginal candidosis in susceptible women. We addressed the question whether oral antifungal treatment for vulvo-Vaginal candidosis also influences the bacterial Vaginal microflora. One hundred and forty-two patients with a culture-proven acute episode of recurrent vulvo-Vaginal candidosis (RVC) were treated with fuconazole according to the ReCiDiF regimen (induction dose of 600 mg orally per week followed by 200 mg per week) or with a single dose of 200 mg pramiconazole, a new potent oral triazole. At inclusion, 1 week and 1 month after the end of antifungal treatment, the bacterial microflora was assessed by microscopy of Vaginal fluid to detect lactobacillary grades and bacterial vaginosis (BV). The presence of BV was studied in these patients with vulvo-Vaginal candidosis after treatment with antifungal medication. At the start of oral antifungal treatment, 6.3% of women with Candida were co-infected with BV. Of the BV-negative women, 10 out of 133 (8%) developed BV after 1 week and after 1 month 8 of them (7%) were still BV-positive. Although no patients received antibacterial treatment at any moment of the study, 6 out of 9 (66%) of the women with Candida and BV at inclusion no longer had BV 1 week after antifungal treatment and 6 out of 7 (86%) lacked BV after 1 month. Treatment with antifungals may have a beneficial effect on women with concurrent BV, but does not prevent BV from occurring in BV-negative women with Candida vaginitis.
Formulary Staff - One of the best experts on this subject based on the ideXlab platform.
-
FDA warns fluconazole in early pregnancy may cause birth defects
2011Co-Authors: Formulary StaffAbstract:FDA issued a warning this week that chronic high doses (400 mg/day to 800 mg/day) of fluconazole (Diflucan) during the first trimester of pregnancy may be associated with specific birth defects in infants. However, the risk does not appear to be associated with a single, low dose of fluconazole (150 mg), which is used to treat Vaginal Yeast Infection (candidiasis), according to the Safety Alert released August 3.
From Staff Reports - One of the best experts on this subject based on the ideXlab platform.
-
Fluconazole in early pregnancy may cause birth defects, FDA warns
Formulary, 2011Co-Authors: From Staff ReportsAbstract:FDA issued a warning last week that chronic high doses (400 mg/day to 800 mg/day) of fluconazole (Diflucan) during the first trimester of pregnancy may be associated with specific birth defects in infants. However, according to the Safety Alert released August 3, the risk does not appear to be associated with the single low dose of fluconazole (150 mg) that is used to treat Vaginal Yeast Infection (candidiasis).
